Cargando…
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
Glioblastoma is an aggressive primary brain tumor that has seen few advances in treatments for over 20 years. In response to this desperate clinical need, multiple immunotherapy strategies are under development, including CAR-T cells, immune checkpoint inhibitors, oncolytic viruses and dendritic cel...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623138/ https://www.ncbi.nlm.nih.gov/pubmed/37928547 http://dx.doi.org/10.3389/fimmu.2023.1261257 |